Back
Bionano Genomics Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
11
BNGO
Bionano Genomics
Last Price:
0.22
Seasonality Move:
400.39%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.Bionano Genomics Price Quote
$0.22
0.00 (0.41%)
(Updated: November 23, 2024 at 5:27 AM ET)
Bionano Genomics Key Stats
Sell
11
Bionano Genomics (BNGO)
is a Sell
Day range:
$0.22 - $0.23
52-week range:
$0.20 - $2.27
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.31
P/B ratio:
0.47%
Volume:
2.9M
Avg. volume:
3.4M
1-year change:
-84.55%
Market cap:
$22.8M
Revenue:
$36.1M
EPS:
$-4.48
How Much Does Bionano Genomics Make?
-
How Much Are Bionano Genomics's Sales Annually?
BNGO Revenues are $36.1M -
How Much Profit Does Bionano Genomics's Make A Year?
BNGO net income is -$232.5M
Is Bionano Genomics Growing As A Company?
-
What Is Bionano Genomics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.35% -
What Is Bionano Genomics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Bionano Genomics Stock Price Performance
-
Did Bionano Genomics Stock Go Up Last Month?
Bionano Genomics share price went down by -27.2% last month -
Did BNGO's Share Price Rise Over The Last Year?
BNGO share price fell by -84.55% over the past 1 year
What Is Bionano Genomics 52-Week High & Low?
-
What Is Bionano Genomics’s 52-Week High Share Price?
Bionano Genomics has traded as high as $2.27 over the past 52 weeks -
What Is Bionano Genomics’s 52-Week Low Share Price?
Bionano Genomics has traded as low as $0.20 over the past 52 weeks
Bionano Genomics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Bionano Genomics?
-
How Much Debt Does Bionano Genomics Have?
Total long term debt quarterly is $15M -
How Much Cash Does Bionano Genomics Have?
Cash and short term investments quarterly total is $23M -
What Is Bionano Genomics’s Book Value Per Share?
Book value per share is 0.55
Is Bionano Genomics Cash Flow Positive?
-
What Is BNGO Cash Flow From Operations?
Cash flow from operations (TTM) is -$92.2M -
What Is Bionano Genomics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $50.9M -
What Is Bionano Genomics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $15.5M
Bionano Genomics Return On Invested Capital
-
Is Management Doing A Good Job?
BNGO return on invested capital is -121.16% -
What Is Bionano Genomics Return On Assets?
ROA measures how assets are converting to revenues and is -88.05% -
What Is BNGO Return On Equity?
ROE is a measure of profitability and is -158.95%
Bionano Genomics Earnings Date & Stock Price
-
What Is Bionano Genomics's Stock Price Today?
A single share of BNGO can be purchased today for 0.22 -
What Is Bionano Genomics’s Stock Symbol?
Bionano Genomics trades on the nasdaq under the ticker symbol: BNGO -
When Is Bionano Genomics’s Next Earnings Date?
The next quarterly earnings date for Bionano Genomics is scheduled on March 5, 2025 -
When Is BNGO's next ex-dividend date?
Bionano Genomics's next ex-dividend date is November 24, 2024 -
How To Buy Bionano Genomics Stock?
You can buy Bionano Genomics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Bionano Genomics Competitors
-
Who Are Bionano Genomics's Competitors?
Below is a list of companies who compete with Bionano Genomics or are related in some way:
Bionano Genomics Dividend Yield
-
What Is BNGO Dividend Yield?
Bionano Genomics’s dividend yield currently is 0% -
What Is Bionano Genomics’s Payout Ratio?
Bionano Genomics’s payout ratio is 0% -
When Did Bionano Genomics Last Pay A Dividend?
The latest dividend pay date is November 24, 2024 -
What Is Bionano Genomics’s Dividend Per Share?
Bionano Genomics pays a dividend of $0.00 per share
Bionano Genomics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -67.19% |
| Revenue: | -34.83% | -22.63% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 4 |
| Sell Recommendations: | 0 |
| Price Target: | 1.00 |
| Upside from Last Price: | 346.43% |